Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Aceso Life Science Group Limited (0474) Stock Price & Analysis

0 Followers

0474 Stock Chart & Stats

HK$0.14HK$0.00(0.00%)
At close: 4:00 PM GMT+8
HK$0.12HK$0.14HK$0.16Aug 17Aug 31Sep 14Sep 28Oct 12Oct 26Nov 9
Day’s Range
HKD 0.14 - HKD 0.14
52-Week Range
HKD 0.09 - HKD 0.16
Previous Close
HKD 0.14
Volume
N/A
Average Volume (3M)
242.09K
Market Cap
HKD 1.24B
Enterprise Value
HKD 1.89B
Total Cash (Recent Filing)
HKD 345.00M
Total Debt (Recent Filing)
HKD 1.19B
Price to Earnings (P/E)
3.0
Beta
0.32
Next Earnings
Dec 01, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Aug 14, 2009
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Balance-sheet Repair

Lower debt and higher equity in 2026 represent a meaningful improvement from the prior year’s exceptionally thin equity base. This repair can reduce balance-sheet strain and provide somewhat greater financial flexibility, although leverage remains elevated.

Return To Positive Free Cash Flow

The return to positive free cash flow indicates that the business has recently generated cash after investment needs, a necessary foundation for funding operations and servicing obligations. However, the modest scale and prior volatility limit confidence in consistent cash generation.

Sharp Earnings Rebound

The move from deep losses to a large reported profit improves the company’s near-term financial position and demonstrates potential for earnings recovery. Its durability remains uncertain because operating profitability is weak and the rebound may include non-operating or one-off effects.

Bears Say

Sharp Revenue Contraction

A steep annual revenue decline following a strong prior year signals an unstable top-line trajectory and makes future earnings harder to forecast. Persistent revenue volatility can weaken operating leverage, reduce reinvestment capacity, and undermine the durability of the recent profit rebound.

Weak Operating Profitability

Negative operating margins across most years indicate that reported profits have not consistently been supported by core business operations. This weakens earnings quality and raises the risk that future results will remain volatile if non-operating or one-off contributions do not recur.

Heavy Leverage

High debt relative to equity leaves the company exposed to financial stress and reduces flexibility to fund growth, absorb operating setbacks, or manage weaker cash generation. Although 2026 improved versus 2025, leverage remains a material constraint on longer-term stability.

Aceso Life Science Group Limited News

0474 FAQ

What was Aceso Life Science Group Limited’s price range in the past 12 months?
Aceso Life Science Group Limited lowest stock price was HK$0.09 and its highest was HK$0.16 in the past 12 months.
What is Aceso Life Science Group Limited’s market cap?
Aceso Life Science Group Limited’s market cap is HK$1.24B.
When is Aceso Life Science Group Limited’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Aceso Life Science Group Limited’s earnings last quarter?
Aceso Life Science Group Limited released its earnings results on Jun 26, 2026. The company reported -HK$0.005 earnings per share for the quarter.
Is Aceso Life Science Group Limited overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Aceso Life Science Group Limited pay dividends?
Aceso Life Science Group Limited pays an annual dividend of HK$0.06 which represents an annual dividend yield of ―. See more information on Aceso Life Science Group Limited dividends here
What is Aceso Life Science Group Limited’s EPS estimate?
Aceso Life Science Group Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aceso Life Science Group Limited have?
Aceso Life Science Group Limited has 8,858,127,000 shares outstanding.
What happened to Aceso Life Science Group Limited’s price movement after its last earnings report?
Aceso Life Science Group Limited reported an EPS of -HK$0.005 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Aceso Life Science Group Limited?
Currently, no hedge funds are holding shares in HK:0474
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology